
Rajiv Ambrish Agarwal
About Rajiv Ambrish Agarwal
Data last updated:
Rajiv Ambrish Agarwal is a Director at Concord Biotech Limited (since 2008), Director at Aptech Limited (since 2006) and Director at Equirus Capital Private Limited (since 2010), and holds 4 more current directorships. The companies operate in Chemicals, Education and Financial Services. The 6 current companies with reported revenue have a combined latest revenue of ₹2,669 Cr; the largest is Concord Biotech Limited at ₹888 Cr (FY 2023). Earlier, Rajiv Ambrish Agarwal was a Director at Nazara Technologies Limited (2020–2025) and Director at Cinestaan Entertainment Private Limited (2017–2023) and 7 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Jun 2008 | 1984 | ₹888 Cr (FY 2023) | Active | |
| Director | 29 Oct 2006 | 2000 | ₹520 Cr (FY 2026) | Active | |
| Director | 10 Aug 2010 | 2007 | ₹413 Cr (FY 2026) | Active | |
| Director | 17 Jun 2019 | 1999 | ₹344 Cr (FY 2025) | Active | |
| Director | 14 Feb 2020 | 2010 | ₹259 Cr (FY 2025) | Active | |
| Director | 01 Sep 2008 | 1999 | ₹244 Cr (FY 2024) | Active | |
| Designated Partner | 01 Jan 2014 | 2014 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Jun 2020 | 1999 | ₹3,073 Cr (FY 2026) | Active | |
| Director | 27 May 2017 | 2013 | ₹4.4 Lakh (FY 2025) | Active | |
| Director | 27 Dec 2005 | 1992 | ₹1,624 Cr (FY 2023) | Active | |
| Director | 20 Jul 2006 | 2006 | ₹280 Cr (FY 2025) | Active | |
| Director | 08 May 2008 | 1987 | ₹842 Cr (FY 2025) | Active | |
| Director | 08 Dec 2011 | 2011 | ₹10.1 Lakh (FY 2021) | Active | |
| Alternate Director | 31 Jan 2007 | 1965 | ₹141 Cr (FY 2025) | Active | |
| Designated Partner | 18 Sep 2018 | 2018 | Active | ||
| Director | 17 Jan 2012 | 2012 | ₹67.62 Cr (FY 2016) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rajiv Ambrish Agarwal
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajiv Ambrish Agarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajiv Ambrish Agarwal
Rajiv Ambrish Agarwal currently holds 7 directorships: Concord Biotech Limited (Director, since 30 Jun 2008, revenue ₹888 Cr (FY 2023)); Aptech Limited (Director, since 29 Oct 2006, revenue ₹520 Cr (FY 2026)); Equirus Capital Private Limited (Director, since 10 Aug 2010, revenue ₹413 Cr (FY 2026)); Alchemy Capital Management Private Limited (Director, since 17 Jun 2019, revenue ₹344 Cr (FY 2025)); Fullife Healthcare Private Limited (Director, since 14 Feb 2020, revenue ₹259 Cr (FY 2025)); and 2 more.
Rajiv Ambrish Agarwal was first appointed on 27 Dec 2005 as Director at Quality Care India Limited. The most recent appointment on record is 22 Jun 2020 at Nazara Technologies Limited.
The 6 current companies of Rajiv Ambrish Agarwal that report revenue have a combined latest revenue of ₹2,669 Cr: Concord Biotech Limited ₹888 Cr (FY 2023); Aptech Limited ₹520 Cr (FY 2026); Equirus Capital Private Limited ₹413 Cr (FY 2026); Alchemy Capital Management Private Limited ₹344 Cr (FY 2025); Fullife Healthcare Private Limited ₹259 Cr (FY 2025); and 1 more.
Rajiv Ambrish Agarwal held 9 earlier board appointments: Nazara Technologies Limited (Director, 22 Jun 2020 to 13 Aug 2025); Cinestaan Entertainment Private Limited (Director, 27 May 2017 to 04 May 2023); Quality Care India Limited (Director, 27 Dec 2005 to 30 Mar 2012); Mel Training & Assessments Limited (Director, 20 Jul 2006 to 01 Apr 2011); John Energy Limited (Director, 08 May 2008 to 02 Sep 2018); and 4 more.
The current boards of Rajiv Ambrish Agarwal's companies include Amitabh Gajendra Thakore (Concord Biotech Limited), Ankur Vaid (Concord Biotech Limited), Arvind Motilal Agarwal (Concord Biotech Limited), Bharti Khanna (Concord Biotech Limited), Chakravarthy Sriraman Mandayam (Concord Biotech Limited), Ekta Gupta (Concord Biotech Limited), among others.